Lexeo Therapeutics, Inc. Common Stock Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.69 | -$0.69 | -$0.69 |
| Q2 2024 | 7 | -$0.77 | -$0.58 | -$0.68 |
| Q3 2024 | 4 | -$0.97 | -$0.50 | -$0.77 |
| Q1 2025 | 2 | -$0.95 | -$0.53 | -$0.74 |
| Q2 2025 | 1 | -$0.76 | -$0.76 | -$0.76 |
| Q3 2025 | 1 | -$0.75 | -$0.75 | -$0.75 |
| Q4 2025 | 1 | -$0.77 | -$0.77 | -$0.77 |
| Q1 2026 | 1 | -$0.74 | -$0.74 | -$0.74 |
| Q2 2026 | 1 | -$0.77 | -$0.77 | -$0.77 |
| Q3 2026 | 1 | -$0.80 | -$0.80 | -$0.80 |
| Q4 2026 | 1 | -$0.77 | -$0.77 | -$0.77 |
Lexeo Therapeutics, Inc. Common Stock Earnings Date And Information
Lexeo Therapeutics, Inc. Common Stock last posted its earnings results on Monday, August 12th, 2024. The company reported $-0.64 earnings per share for the quarter, topping analysts' consensus estimates of $-0.69 by $0.05. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Lexeo Therapeutics, Inc. Common Stock has generated $-2 earnings per share over the last year ($-2.49 diluted earnings per share) and currently has a price-to-earnings ratio of -2.29. Lexeo Therapeutics, Inc. Common Stock has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, December 9th, 2024 based on prior year's report dates.
Lexeo Therapeutics, Inc. Common Stock Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$0.89 | $0 | $0 | ||
| 08/12/2024 | Q2 2024 | -$0.69 | -$0.64 | 0.05 | $0 | $0 |
| 05/09/2024 | Q1 2024 | -$0.76 | -$0.77 | -0.01 | $0 | |
| 03/11/2024 | Q4 2023 | -$0.71 | -$0.53 | 0.18 | $0 | |
| 12/11/2023 | Q3 2023 | -$0.80 | $0 | |||
| 06/29/2023 | Q2 2023 | -$0.54 | $0 | |||
| 03/30/2023 | Q1 2023 | -$0.74 | $0 | |||
| 12/30/2022 | Q4 2022 | $0.00 | $0 | |||
| 09/29/2022 | Q3 2022 | -$0.68 | $0 | |||
| 06/29/2022 | Q2 2022 | -$0.61 | $37,000 | |||
| 03/29/2022 | Q1 2022 | -$0.47 | $85,550 |
Lexeo Therapeutics, Inc. Common Stock Earnings: Frequently Asked Questions
-
When is Lexeo Therapeutics, Inc. Common Stock's earnings date?
Lexeo Therapeutics, Inc. Common Stock has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, December 9th, 2024 based off last year's report dates.
-
Did Lexeo Therapeutics, Inc. Common Stock beat their earnings estimates last quarter?
In the previous quarter, Lexeo Therapeutics, Inc. Common Stock (:LXEO) reported $-0.64 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.69 by $0.05.
-
How can I listen to Lexeo Therapeutics, Inc. Common Stock's earnings conference call?
The conference call for Lexeo Therapeutics, Inc. Common Stock's latest earnings report can be listened to online.
-
How can I read Lexeo Therapeutics, Inc. Common Stock's conference call transcript?
The conference call transcript for Lexeo Therapeutics, Inc. Common Stock's latest earnings report can be read online.
-
How much profit does Lexeo Therapeutics, Inc. Common Stock generate each year?
Lexeo Therapeutics, Inc. Common Stock (:LXEO) has a recorded net income of $0. Lexeo Therapeutics, Inc. Common Stock has generated $-2.49 earnings per share over the last four quarters.
-
What is Lexeo Therapeutics, Inc. Common Stock's price-to-earnings ratio?
Lexeo Therapeutics, Inc. Common Stock (:LXEO) has a price-to-earnings ratio of -2.29 and price/earnings-to-growth ratio is 0.7.
